| CPRX - Catalyst Pharmaceuticals Inc (Healthcare: Biotechnology) | Projected Earnings Date: 2024-08-12 (Delayed quote data 2025-06-30) |
|
|
|||||||||||||||||
|
|
|
| Company Profile | |
| Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing innovative therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with the lambert-eaton myasthenic syndrome. | |
| Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. |